Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001193125-26-009156

Options or other derivatives

  • Chief Financial Officer acquired 412,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Broadfoot Jill Marie · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-09 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +412,500 412,500 D
Loading xslF345X05/ownership.xml…